Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Natera, Inc. (NTRA) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Natera, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1604821.
Total stock buying since 2010: $38,028,527.
Total stock sales since 2010: $607,865,813.
Total stock option exercises since 2010: $36,707,279.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 695,255 | $109,438,748 | 164,381 | $298,661 |
| 2024 | 0 | $0 | 1,391,679 | $151,027,380 | 1,443,362 | $9,563,081 |
| 2023 | 0 | $0 | 998,325 | $54,976,421 | 204,815 | $51,233 |
| 2022 | 372,820 | $11,333,329 | 118,530 | $6,709,037 | 708,166 | $2,136,786 |
| 2021 | 2,400 | $271,200 | 851,702 | $90,803,598 | 1,109,643 | $6,173,832 |
| 2020 | 0 | $0 | 1,524,635 | $98,705,367 | 1,257,027 | $10,726,622 |
| 2019 | 0 | $0 | 891,193 | $26,836,840 | 1,624,664 | $3,661,602 |
| 2018 | 0 | $0 | 2,065,668 | $48,182,022 | 447,484 | $2,958,308 |
| 2017 | 0 | $0 | 127,268 | $1,576,266 | 20,000 | $0 |
| 2016 | 921,273 | $10,999,998 | 1,425,435 | $16,953,534 | 510,325 | $302,685 |
| 2015 | 750,000 | $15,424,000 | 245,317 | $2,656,600 | 208,124 | $1,164 |
| 2010 | 0 | $0 | 0 | $0 | 32,730 | $833,305 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 21,676 | $3,158,624 | 0 | $0 |
| 2025-07 | 0 | $0 | 43,556 | $6,510,698 | 11,503 | $104,981 |
| 2025-06 | 0 | $0 | 44,089 | $7,323,775 | 0 | $0 |
| 2025-05 | 0 | $0 | 72,137 | $11,104,570 | 4,000 | $97,680 |
| 2025-04 | 0 | $0 | 53,929 | $7,829,814 | 11,203 | $64,560 |
| 2025-03 | 0 | $0 | 178,052 | $25,769,201 | 31,500 | $31,440 |
| 2025-02 | 0 | $0 | 51,497 | $9,011,901 | 0 | $0 |
| 2025-01 | 0 | $0 | 230,319 | $38,730,165 | 106,175 | $0 |
| 2024-12 | 0 | $0 | 259,798 | $43,451,690 | 68,496 | $369,535 |
| 2024-11 | 0 | $0 | 99,852 | $15,111,244 | 177,230 | $1,634,857 |
| 2024-10 | 0 | $0 | 28,895 | $3,544,244 | 10,911 | $0 |
| 2024-09 | 0 | $0 | 29,638 | $3,790,921 | 2,614 | $246,081 |
| 2024-08 | 0 | $0 | 24,239 | $2,889,178 | 190,000 | $1,025,049 |
| 2024-07 | 0 | $0 | 72,240 | $7,766,219 | 11,010 | $539 |
| 2024-06 | 0 | $0 | 8,805 | $977,342 | 55,000 | $0 |
| 2024-05 | 0 | $0 | 52,286 | $5,508,423 | 245,000 | $1,750,325 |
| 2024-04 | 0 | $0 | 132,706 | $12,132,923 | 10,910 | $0 |
| 2024-03 | 0 | $0 | 407,415 | $36,037,580 | 97,481 | $2,246,077 |
| 2024-02 | 0 | $0 | 234,044 | $17,110,441 | 563,799 | $2,290,618 |
| 2024-01 | 0 | $0 | 41,761 | $2,707,175 | 10,911 | $0 |
| 2023-12 | 0 | $0 | 656,571 | $38,601,222 | 9,285 | $0 |
| 2023-11 | 0 | $0 | 11,564 | $549,140 | 0 | $0 |
| 2023-10 | 0 | $0 | 8,673 | $350,608 | 10,911 | $0 |
| 2023-09 | 0 | $0 | 27,088 | $1,464,546 | 9,285 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-28 | Chapman Rowan E | Sale | 2,750 | 166.99 | 459,222 |
| 2025-08-14 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 678 | 155.38 | 105,347 |
| 2025-08-14 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 875 | 155.44 | 136,011 |
| 2025-08-11 | Sheena Jonathan | Sale | 3,000 | 153.33 | 459,981 |
| 2025-08-08 | Sheena Jonathan | Sale | 3,070 | 160.97 | 494,190 |
| 2025-08-01 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 3,000 | 133.28 | 399,843 |
| 2025-08-01 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 5,807 | 132.87 | 771,576 |
| 2025-08-01 | Marcus Gail Boxer | Sale | 2,496 | 133.19 | 332,454 |
| 2025-07-29 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 3,045 | 137.15 | 417,609 |
| 2025-07-28 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 1,710 | 139.81 | 239,071 |
| 2025-07-28 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 2,206 | 139.81 | 308,416 |
| 2025-07-28 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 1,994 | 139.81 | 278,777 |
| 2025-07-28 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 6,092 | 139.81 | 851,710 |
| 2025-07-28 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 2,019 | 139.81 | 282,272 |
| 2025-07-28 | Sheena Jonathan | Sale | 479 | 139.81 | 66,968 |
| 2025-07-28 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 1,718 | 139.81 | 240,190 |
| 2025-07-24 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 755 | 139.58 | 105,379 |
| 2025-07-23 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 495 | 141.28 | 69,933 |
| 2025-07-22 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 920 | 139.58 | 128,415 |
| 2025-07-22 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Option Ex | 1,250 | .00 | 0 |
| 2025-07-21 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 339 | 139.29 | 47,219 |
| 2025-07-21 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 291 | 139.29 | 40,533 |
| 2025-07-21 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 464 | 139.29 | 64,630 |
| 2025-07-21 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 1,622 | 139.29 | 225,928 |
| 2025-07-21 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 602 | 139.29 | 83,852 |
| 2025-07-21 | Sheena Jonathan | Sale | 93 | 139.29 | 12,953 |
| 2025-07-20 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Option Ex | 856 | .00 | 0 |
| 2025-07-20 | Chapman Steven Leonard (CEO AND PRESIDENT) | Option Ex | 3,386 | .00 | 0 |
| 2025-07-20 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Option Ex | 1,522 | .00 | 0 |
| 2025-07-20 | Sheena Jonathan | Option Ex | 190 | .00 | 0 |
| 2025-07-16 | Sheena Jonathan | Sale | 3,070 | 149.96 | 460,389 |
| 2025-07-02 | Sheena Jonathan | Sale | 3,000 | 160.18 | 480,545 |
| 2025-07-01 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 3,000 | 166.22 | 498,675 |
| 2025-07-01 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 5,343 | 166.20 | 887,995 |
| 2025-07-01 | Marcus Gail Boxer | Sale | 4,299 | 167.30 | 719,239 |
| 2025-07-01 | Marcus Gail Boxer | Option Ex | 4,299 | 24.42 | 104,981 |
| 2025-06-20 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 9,908 | 171.06 | 1,694,902 |
| 2025-06-18 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 10,000 | 170.18 | 1,701,800 |
| 2025-06-18 | Sheena Jonathan | Sale | 3,070 | 167.29 | 513,571 |
| 2025-06-16 | Sheena Jonathan | Sale | 3,000 | 163.98 | 491,946 |
| 2025-06-13 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 5,000 | 165.85 | 829,250 |
| 2025-06-10 | Marcus Gail Boxer | Sale | 4,000 | 164.69 | 658,756 |
| 2025-06-02 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 3,000 | 157.76 | 473,268 |
| 2025-06-02 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 6,111 | 157.14 | 960,282 |
| 2025-05-28 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 10,000 | 161.00 | 1,610,000 |
| 2025-05-27 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 1,438 | 156.85 | 225,551 |
| 2025-05-27 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 1,649 | 156.85 | 258,647 |
| 2025-05-20 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 10,000 | 153.90 | 1,539,000 |
| 2025-05-16 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 19,000 | 152.85 | 2,904,150 |
| 2025-05-15 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 10,000 | 150.20 | 1,502,000 |
| 2025-05-12 | Sheena Jonathan | Sale | 3,000 | 158.24 | 474,729 |
| 2025-05-09 | Sheena Jonathan | Sale | 3,070 | 159.52 | 489,726 |
| 2025-05-01 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 3,000 | 150.40 | 451,185 |
| 2025-05-01 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 6,980 | 150.37 | 1,049,610 |
| 2025-05-01 | Marcus Gail Boxer | Sale | 4,000 | 149.99 | 599,972 |
| 2025-05-01 | Marcus Gail Boxer | Option Ex | 4,000 | 24.42 | 97,680 |
| 2025-04-29 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 3,045 | 154.26 | 469,709 |
| 2025-04-28 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 1,709 | 152.18 | 260,079 |
| 2025-04-28 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 2,206 | 152.18 | 335,713 |
| 2025-04-28 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 1,993 | 152.18 | 303,298 |
| 2025-04-28 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 6,203 | 152.18 | 943,984 |
| 2025-04-28 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 2,018 | 152.18 | 307,103 |
| 2025-04-28 | Sheena Jonathan | Sale | 439 | 152.18 | 66,807 |
| 2025-04-28 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 1,718 | 152.18 | 261,448 |
| 2025-04-24 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 755 | 152.46 | 115,103 |
| 2025-04-23 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 495 | 150.74 | 74,616 |
| 2025-04-22 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 911 | 144.83 | 131,937 |
| 2025-04-22 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Option Ex | 1,250 | .00 | 0 |
| 2025-04-21 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 343 | 145.82 | 50,016 |
| 2025-04-21 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 296 | 146.19 | 43,273 |
| 2025-04-21 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 470 | 145.85 | 68,549 |
| 2025-04-21 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 1,664 | 145.81 | 242,621 |
| 2025-04-21 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 610 | 145.85 | 88,968 |
| 2025-04-21 | Sheena Jonathan | Sale | 86 | 145.85 | 12,543 |
| 2025-04-20 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Option Ex | 856 | .00 | 0 |
| 2025-04-20 | Chapman Steven Leonard (CEO AND PRESIDENT) | Option Ex | 3,386 | .00 | 0 |
| 2025-04-20 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Option Ex | 1,521 | .00 | 0 |
| 2025-04-20 | Sheena Jonathan | Option Ex | 190 | .00 | 0 |
| 2025-04-04 | Sheena Jonathan | Sale | 3,070 | 134.09 | 411,668 |
| 2025-04-03 | Sheena Jonathan | Sale | 3,000 | 139.28 | 417,846 |
| 2025-04-01 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 3,000 | 140.79 | 422,370 |
| 2025-04-01 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 15,898 | 140.75 | 2,237,595 |
| 2025-04-01 | Marcus Gail Boxer | Sale | 4,000 | 141.14 | 564,568 |
| 2025-04-01 | Marcus Gail Boxer | Option Ex | 4,000 | 16.14 | 64,560 |
| 2025-03-31 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 1,404 | 138.40 | 194,312 |
| 2025-03-31 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 9,563 | 138.41 | 1,323,643 |
| 2025-03-31 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 2,562 | 138.38 | 354,542 |
| 2025-03-28 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Option Ex | 2,500 | .00 | 0 |
| 2025-03-28 | Chapman Steven Leonard (CEO AND PRESIDENT) | Option Ex | 18,750 | .00 | 0 |
| 2025-03-28 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Option Ex | 6,250 | .00 | 0 |
| 2025-03-18 | Sheena Jonathan | Sale | 5,700 | 145.92 | 831,755 |
| 2025-03-17 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 795 | 147.80 | 117,501 |
| 2025-03-17 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 1,026 | 147.88 | 151,728 |
| 2025-03-17 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 928 | 147.88 | 137,236 |
| 2025-03-17 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 6,702 | 146.03 | 978,679 |
| 2025-03-17 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 792 | 147.80 | 117,058 |
| 2025-03-17 | Sheena Jonathan | Sale | 181 | 146.03 | 26,431 |
| 2025-03-17 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 1,127 | 147.80 | 166,571 |
| 2025-03-14 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 50,000 | 147.39 | 7,369,650 |
| 2025-03-12 | Marcus Gail Boxer | Sale | 4,000 | 147.76 | 591,048 |
| 2025-03-12 | Marcus Gail Boxer | Option Ex | 4,000 | 7.86 | 31,440 |
| 2025-03-05 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 6,000 | 143.56 | 861,341 |
| 2025-03-05 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 87,272 | 143.78 | 12,547,706 |
| 2025-02-26 | Sheena Jonathan | Sale | 5,700 | 159.67 | 910,113 |
| 2025-02-06 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 663 | 177.77 | 117,861 |
| 2025-02-06 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 1,632 | 177.77 | 290,120 |
| 2025-02-03 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 43,502 | 176.86 | 7,693,807 |
| 2025-01-31 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 2,286 | 174.82 | 402,287 |
| 2025-01-31 | Sheena Jonathan | Sale | 163 | 176.60 | 28,785 |
| 2025-01-29 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 4,030 | 166.38 | 670,495 |
| 2025-01-29 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 5,201 | 166.37 | 865,269 |
| 2025-01-29 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 4,773 | 166.31 | 793,807 |
| 2025-01-29 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 13,685 | 166.61 | 2,280,030 |
| 2025-01-29 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 4,335 | 166.47 | 721,664 |
| 2025-01-29 | Sheena Jonathan | Sale | 1,054 | 166.51 | 175,505 |
| 2025-01-29 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 6,003 | 166.61 | 1,000,183 |
| 2025-01-27 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 1,442 | 161.87 | 233,416 |
| 2025-01-24 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 946 | 172.12 | 162,825 |
| 2025-01-23 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 495 | 171.09 | 84,689 |
| 2025-01-22 | Fesko John (PRESIDENT, CHIEF BUS. OFFICER) | Sale | 21,228 | 168.46 | 3,575,962 |
| 2025-01-22 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 24,861 | 168.45 | 4,187,885 |
| 2025-01-22 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 22,039 | 168.45 | 3,712,425 |
| 2025-01-22 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 78,553 | 168.46 | 13,232,959 |
| 2025-01-22 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Sale | 25,931 | 168.45 | 4,367,999 |
| 2025-01-22 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Option Ex | 1,250 | .00 | 0 |
| 2025-01-22 | Sheena Jonathan | Sale | 971 | 168.43 | 163,544 |
| 2025-01-21 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Option Ex | 644 | .00 | 0 |
| 2025-01-21 | Chapman Steven Leonard (CEO AND PRESIDENT) | Option Ex | 1,775 | .00 | 0 |
| 2025-01-21 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Option Ex | 1,145 | .00 | 0 |
| 2025-01-21 | Sheena Jonathan | Option Ex | 144 | .00 | 0 |
| 2025-01-20 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Option Ex | 856 | .00 | 0 |
| 2025-01-20 | Chapman Steven Leonard (CEO AND PRESIDENT) | Option Ex | 3,386 | .00 | 0 |
| 2025-01-20 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Option Ex | 1,522 | .00 | 0 |
| 2025-01-20 | Sheena Jonathan | Option Ex | 191 | .00 | 0 |
| 2025-01-16 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Option Ex | 13,696 | .00 | 0 |
| 2025-01-16 | Chapman Steven Leonard (CEO AND PRESIDENT) | Option Ex | 54,175 | .00 | 0 |
| 2025-01-16 | Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) | Option Ex | 24,348 | .00 | 0 |
| 2025-01-16 | Sheena Jonathan | Option Ex | 3,043 | .00 | 0 |
| 2025-01-08 | Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) | Sale | 6,223 | 175.30 | 1,090,904 |
| 2025-01-02 | Sheena Jonathan | Sale | 5,700 | 159.70 | 910,312 |
| 2024-12-18 | Sheena Jonathan | Sale | 5,700 | 167.10 | 952,452 |
| 2024-12-13 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 160,000 | 166.45 | 26,632,160 |
| 2024-12-10 | Chapman Rowan E | Sale | 1,767 | 170.24 | 300,808 |
| 2024-12-09 | Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) | Sale | 4,858 | 166.59 | 809,313 |
| 2024-12-05 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Option Ex | 68,496 | 5.39 | 369,535 |
| 2024-12-02 | Botha Roelof (Director) | Sale | 87,473 | 168.70 | 14,756,957 |
| 2024-11-26 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 2,000 | 164.35 | 328,692 |
| 2024-11-25 | Rabinowitz Matthew (EXECUTIVE CHAIRMAN) | Sale | 2,000 | 168.91 | 337,826 |
| 2024-11-19 | Marcus Gail Boxer | Sale | 9,682 | 160.18 | 1,550,814 |
| 2024-11-15 | Chapman Steven Leonard (CEO AND PRESIDENT) | Sale | 4,728 | 147.14 | 695,668 |
Insider trading activities including stock purchases, stock sales, and option exercises of NTRA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Natera, Inc. (symbol NTRA, CIK number 1604821) see the Securities and Exchange Commission (SEC) website.